May 2020 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2019/20 Invitation to Tender, dated 1 November 2019.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by:
- For new listings, by 4pm on 12 June 2020 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
PHARMAC cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
Download the Tender results
- Tender Results 29 05 2020 [PDF 105 KB]
2019/20 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2023
CORRECTION to February 2020 tender notification
PHARMAC incorrectly notified a Sole Subsidised Supply Status award in February 2020 for gemcitabine hydrochloride injection in Section B (community) when this should have been an award for Hospital Supply Status in Part II of Section H (Hospital Medicines List). Correction in strikethrough and bold below:
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
Chemical name |
Presentation; |
Current |
New |
Hospital supply brand |
DV |
Listing date |
Hospital Supply Status date |
---|---|---|---|---|---|---|---|
Gemcitabine |
Inj 10 mg per ml, 100 ml vial; |
$15.89 |
$15.89 |
Gemcitabine Ebewe |
1% |
1 April 2020 |
1 July 2020 |
CORRECTION to April 2020 tender notification
PHARMAC incorrectly notified the dates relating to the bisoprolol fumarate tablet tender awards. Corrections are in bold and strikethrough below.
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
3. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
Chemical name |
Presentation; |
Current |
New |
Sole supply brand (Supplier) |
Date of listing |
Sole Subsidised Supply date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|
Bisoprolol fumarate1 |
Tab 2.5 mg; |
$3.53 |
$1.84 |
Bisoprolol Mylan |
|
|
Bosvate |
Bisoprolol fumarate1 |
Tab 5 mg; |
$5.15 |
$2.55 |
Bisoprolol Mylan |
|
|
Bosvate |
Bisoprolol fumarate1 |
Tab 10 mg; |
$9.40 |
$3.62 |
Bisoprolol Mylan |
|
|
Bosvate |
1 Brand switch fee of $4.50 is payable for this product from |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
4. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
Chemical name |
Presentation; |
Current |
New |
Sole supply brand (Supplier) |
Date of listing |
Sole Subsidised Supply date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|
Bisoprolol fumarate |
Tab 2.5 mg; |
$3.53 |
$1.84 |
Bisoprolol Mylan |
|
|
Bosvate |
Bisoprolol fumarate |
Tab 5 mg; |
$5.15 |
$2.55 |
Bisoprolol Mylan |
|
|
Bosvate |
Bisoprolol fumarate |
Tab 10 mg; |
$9.40 |
$3.62 |
Bisoprolol Mylan |
|
|
Bosvate |
2019/20 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2023 - May tender notification
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows (changes in bold):
Chemical name |
Presentation; |
Current |
New |
Sole supply brand (Supplier) |
Date of listing |
Sole Subsidised Supply date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|
Amoxicillin with clavulanic acid |
Tab 500 mg with clavulanic acid 125 mg; |
$1.88 |
$0.89 |
Curam Duo 500/125 |
1 February 2021 |
1 July 2021 |
Augmentin |
Anastrozole |
Tab 1 mg; |
$5.04 |
$4.55 |
Anatrole |
1 November 2020 |
1 April 2021 |
Rolin |
Calcium carbonate |
Tab 1.25 g (500 mg elemental); |
$7.52 |
$6.69 |
Calci-Tab 500 |
1 December 2020 |
1 May 2021 |
Arrow-Calcium |
Emulsifying ointment |
Oint BP: 500 g tub |
$3.59 |
$3.40 |
Emulsifying Ointment ADE |
1 October 2020 |
1 March 2021 |
AFT |
Hydroxyurea [Hydroxycarbamide] 2 |
Cap 500 mg; |
$31.76 |
$23.82 |
Devatis |
1 September 2020 |
1 February 2021 |
Hydrea |
2 Brand switch fee of $4.50 is payable for this product from 1 February 2021 to 30 April 2021 |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows (changes in bold):
Chemical name |
Presentation; |
Current pack price |
New pack price |
Hospital supply brand (Supplier) |
DV Limit |
Listing date |
Hospital Supply Status date |
Brand (Supplier) affected by delisting |
---|---|---|---|---|---|---|---|---|
Amoxicillin with clavulanic acid |
Tab 500 mg with clavulanic acid 125 mg; |
$1.88 |
$0.89 |
Curam Duo 500/125 |
1% |
1 February 2021 |
1 July 2021 |
Augmentin |
Anastrozole |
Tab 1 mg; |
$5.04 |
$4.55 |
Anatrole |
1% |
1 November 2020 |
1 April 2021 |
Rolin |
Calcium carbonate |
Tab 1.25 g (500 mg elemental); |
$7.52 |
$6.69 |
Calci-Tab 500 |
1% |
1 December 2020 |
1 May 2021 |
Arrow-Calcium |
Emulsifying ointment |
Oint BP: 500 g tub |
$3.59 |
$3.40 |
Emulsifying Ointment ADE |
1% |
1 October 2020 |
1 March 2021 |
AFT |
Hydroxyurea [Hydroxycarbamide] |
Cap 500 mg; |
$31.76 |
$23.82 |
Devatis |
1% |
1 September 2020 |
1 February 2021 |
Hydrea |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:
- the 2017/18 Invitation to Tender, dated 2 November 2017, and
- the 2018/19 Invitation to Tender, dated 1 November 2018, and
- the 2019/20 Invitation to Tender, dated 1 November 2019.
2017/18 Invitation to Tender
Chemical name |
Line item |
---|---|
Amoxicillin clavulanate |
Grans for oral liq amoxicillin 400 mg with potassium clavulanate 57 mg per 5 ml |
Chlorhexidine gluconate |
Mouthwash 0.2% |
Diclofenac sodium |
Eye drops 0.1% |
Methotrexate |
Inj 7.5 mg prefilled syringe |
Methotrexate |
Inj 10 mg prefilled syringe |
Methotrexate |
Inj 15 mg prefilled syringe |
Methotrexate |
Inj 20 mg prefilled syringe |
Methotrexate |
Inj 25 mg prefilled syringe |
Methotrexate |
Inj 30 mg prefilled syringe |
Midodrine |
Tab 2.5 mg |
Midodrine |
Tab 5 mg |
Mitozantrone |
Inj 2 mg per ml, 10 ml |
Oxycodone hydrochloride |
Oral liq 1 mg per ml |
2018/19 Invitation to Tender
Chemical name |
Line item |
---|---|
Captopril |
Oral liq 5 mg per ml |
2019/20 Invitation to Tender
Chemical name |
Line item |
---|---|
Amikacin |
Inj 15 mg per ml |
Amiloride with Hydrochlorothiazide |
Tab 5 mg with hydrochlorothiazide 50 mg |
Aminophylline |
Inj 25 mg per ml, 10 ml |
Amoxicillin |
Inj 1 g |
Amoxicillin |
Inj 250 mg |
Amoxicillin |
Inj 500 mg |
Baclofen |
Inj 0.05 mg per ml, 1 ml |
Betaxolol hydrochloride |
Eye drops 0.25% |
Betaxolol hydrochloride |
Eye drops 0.5% |
Bupivacaine hydrochloride |
Inj 1.25 mg per ml, 100 ml bag |
Bupivacaine hydrochloride |
Inj 2.5 mg per ml, 200 ml bag |
Bupivacaine hydrochloride |
Inj 1.25 mg per ml, 500ml bag |
Bupivacaine hydrochloride |
Inj 5 mg per ml, 20 ml ampoule |
Captopril |
Oral liq 5 mg per ml |
Cefotaxime |
Inj 500 mg |
Chlorhexidine gluconate |
Soln 4% |
Chlorhexidine gluconate |
Crm 1% obstetric |
Chlorhexidine gluconate |
Lotn 1% obstetric |
Chloroquine phosphate |
Tab 250 mg |
Cimetidine |
Tab 200 mg |
Cimetidine |
Tab 400 mg |
Clarithromycin |
Tab 250 mg |
Clarithromycin |
Tab 500 mg |
Danazol |
Cap 100 mg |
Danazol |
Cap 200 mg |
Desmopressin |
Nasal drops 100 mcg per ml |
Desmopressin |
Inj 4 mcg per ml, 1 ml |
Desmopressin |
Tab 200 mcg |
Desmopressin |
Inj 15 mcg per ml, 1 ml |
Dextrochlorpheniramine Maleate |
Oral liq 2 mg per 5 ml |
Dinoprostone |
Gel 1 mg |
Dinoprostone |
Gel 2 mg |
Doxycycline |
Tab 20 mg - 50 mg |
Doxycycline |
Inj 100 mg per 20 ml |
Ethinyloestradiol with Desogestrel |
Tab 20 mcg with desogestrel 150 mcg |
Ethinyloestradiol with Desogestrel |
Tab 30 mcg with desogestrel 150 mcg |
Ethinyloestradiol with levonorgestrel |
Tab 50 mcg with levonorgestrel 125 mcg |
Flucloxacillin sodium |
Inj 250 mg |
Flucloxacillin sodium |
Inj 500 mg |
Flucloxacillin Sodium |
Inj 2 g |
Flucytosine |
Cap 500 mg |
Glucose [Dextrose] |
Tab 3.1 g |
Glucose [Dextrose] |
Tab 4 g |
Glucose [Dextrose] |
Tab 1.5 g |
Glucose with sucrose and fructose |
Gel 19.7% with sucrose 35% and fructose 19.7%, 18 g sachet |
Imipramine Hydrochloride |
Tab 10 mg |
Imipramine Hydrochloride |
Tab 25 mg |
Imiquimod |
Crm 5% |
Lidocaine [Lignocaine] |
Crm 4% |
Lithium carbonate |
Cap (immediate-release) 250 mg |
Lithium Carbonate |
Tab (immediate-release) 250 mg |
Lithium Carbonate |
Tab long-acting 400 mg |
Medroxyprogesterone acetate |
Tab 100 mg |
Medroxyprogesterone acetate |
Tab 2.5 mg |
Medroxyprogesterone acetate |
Tab 5 mg |
Medroxyprogesterone acetate |
Tab 10 mg |
Melatonin |
Tab modified-release 2 mg |
Menthol |
Crystals |
Metoclopramide hydrochloride |
Oral liq 5 mg per 5 ml |
Mifepristone |
Tab 200 mg |
Nicardipine hydrochloride |
Inj 2.5 mg per ml, 10 ml vial |
Nitazoxanide |
Oral 100 mg per 5 ml |
Nitazoxanide |
Tab 500 mg |
Noradrenaline |
Inj 0.06 mg per ml, 100 ml bag |
Noradrenaline |
Inj 0.12 mg per ml, 50 ml syringe |
Noradrenaline |
Inj 1 mg per ml, 100 ml bag |
Noradrenaline |
Inj 0.16 mg per ml, 50 ml vial |
Noradrenaline |
Inj 0.16 mg per ml, 100 ml bag |
Oestrogens |
Conjugated, equine tab 300 mcg |
Oestrogens |
Conjugated, equine tab 625 mcg |
Paracetamol |
Tab 500 mg, blister pack |
Paracetamol |
Tab 500 mg, bottle pack |
Paraffin liquid with soft white paraffin |
Eye oint with soft white paraffin |
Paraffin liquid with wool fat liquid |
Eye oint 3% with wool fat liq 3% |
Paraldehyde |
Inj 5 ml |
Perindopril |
Tab 2 mg - 2.5 mg |
Perindopril |
Tab 4 mg – 5 mg |
Perindopril |
Tab 8 mg – 10 mg |
Phenelzine sulphate |
Tab 15 mg |
Pravastatin |
Tab 10 mg |
Procaine penicillin |
Inj 1.5 mega u |
Protionamide |
Tab 250 mg |
Quinine dihydrochloride |
Inj 600 mg |
Rasagiline |
Tab 1 mg |
Rifabutin |
Cap 150 mg |
Sodium cromoglicate |
Nasal spray, 4% |
Tramadol hydrochloride |
Inj 10 mg per ml, 100 ml bag |
Tranylcypromine Sulphate |
Tab 10 mg |
Triamcinolone acetonide |
Inj 10 mg per ml, 1 ml preservative-free |
Wool fat with mineral oil |
Lotn hydrous 3% with mineral oil, 250 ml |
Xylometazoline hydrochloride |
Nasal drops 0.1% |
Xylometazoline hydrochloride |
Aqueous nasal spray 0.05% |
Xylometazoline hydrochloride |
Aqueous nasal spray 0.1% |
Xylometazoline hydrochloride |
Nasal drops 0.05% |
Zuclopenthixol Acetate |
Inj 50 mg per ml, 1 - 2 ml |
Zuclopenthixol Decanoate |
Inj 200 mg per ml |
Zuclopenthixol decanoate |
Inj 500 mg per ml |
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.